Is a complete TCRX research report available?

No complete published report is available for TScan Therapeutics, Inc. (TCRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · USD

$0.80

+0.03 (+4.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-08 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TCRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	52M
Revenue (ttm)	9.1M
Net income (ttm)	-124.3M
EPS (ttm)	-$2.07
Shares out	65.4M
Volume	336,330
Beta	1.07
Price target	$6.00	+653.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.1M
Net income (ttm): -124.3M
EPS (ttm): -$2.07
Market cap: 52M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	29.6B	39.4x	6.2x	96.6%	+47.5%	-49.6%	Strong Buy
ARGX	argenx SE	54.1B	31.5x	10.2x	50.6%	+58.8%	+30.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TCRX indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001783328
Company name	TScan Therapeutics, Inc.
Country	United States
Country code	US
Cusip	89854M101
Employees	139
Employees Change	-3%
Employees Change Percent	-2.11
Enterprise value	$16.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-16
Isin	US89854M1018
Last refreshed	2026-08-08
Market cap	$52M
Market cap category	Nano-Cap
Price	$0.8
Price currency	USD
Rev Per Employee	65,726.62x
Sector	Healthcare
Sector PE	48.94
Sector PE Fwd	22.07
Sic	2836
Symbol	TCRX
Website	https://www.tscan.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-238.9%
EV Sales Forward	2.23x
EV/Sales	1.81x
FCF yield	-240.15%
P/B ratio	0.49x
P/S ratio	5.7x
PS Forward	7.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1,408.73%
EBITDA Margin	-1,377.2%
Gross Profit	$-95.5M
Net Income	$-124.3M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-1,360.61%
Profit Per Employee	$-894,281
ROA	-29.62
Roa5y	-25.19
ROCE	-70.71
ROE	-80.95
Roe5y	-62.64
ROIC	-31.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-54%
Cagr3y	-28.29%
Cagr5y	-40.26%
EPS Growth Quarters	2
EPS Growth Years	6
Revenue Growth	106.65x
Revenue Growth Q	-54.77x
Revenue Growth Years	1x
Revenue Growth3 Y	-19.2x
Revenue Growth5 Y	24.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$202M
Cash	$128.1M
Current Assets	$132.8M
Current Liabilities	$20M
Debt	$92.5M
Debt Equity	$0.95
Equity	$96.9M
Interest Coverage	-46.31
Liabilities	$105.1M
Long Term Assets	$69.2M
Long Term Liabilities	$85.1M
Net Cash	$35.5M
Net Cash By Market Cap	$68.27
Net Cash Growth	-77.03%
Net Debt Equity	$-0.37
Tangible Book Value	$96.9M
Tangible Book Value Per Share	$1.61
WACC	5.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.65
Net Working Capital	$-7.8M
Quick ratio	6.41
Working Capital	$112.8M
Working Capital Turnover	$0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.2%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-53.98%
200-day SMA	1.09
3Y total return	-63.14%
50-day SMA	0.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.39%
All Time High	14.71
All Time High Change	-94.59%
All Time High Date	2021-08-18
All Time Low	0.72
All Time Low Change	11.2%
All Time Low Date	2026-08-04
ATR	0.07
Beta	1.07
Beta1y	3.02
Beta2y	2.05
Ch YTD	-20.38
High	0.8
High52	2.57
High52 Date	2025-10-17
High52ch	-69.02%
Low	0.75
Low52	0.72
Low52 Date	2026-08-04
Low52ch	11.2%
Ma50ch	-13.9%
Premarket Change Percent	-1.18
Premarket Price	$0.75
Premarket Volume	1,818
Price vs 200-day SMA	-26.75%
RSI	43.49
RSI Monthly	34.78
RSI Weekly	39.29
Sharpe ratio	-0.48x
Sortino ratio	-0.6
Total Return	-6.2%
Tr YTD	-20.38
Tr1m	-24.17%
Tr1w	7.16%
Tr3m	-36.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	6
Analyst Price Target Top	$6
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.22
Earnings Revenue Estimate	2,550,000x
Earnings Revenue Estimate Growth	-17.1x
Operating Income	$-126.7M
Operating margin	-1,386.8
Price target	$6
Price Target Change	$654
Price Target Change Top	$654

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,390,172%
Float Percent	84.76%
Shares Insiders	0.18%
Shares Institutions	41.38%
Shares Out	65,350,817
Shares Qo Q	5.62%
Shares Yo Y	6.2%
Short Float	2.5%
Short Ratio	1.42
Short Shares	2.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-135.7M
Adjusted OCF	-132,769,000
Average Volume	602,671.35x
Bv Per Share	1.61
CAPEX	$-2.9M
Ch1m	-24.17
Ch1w	7.16
Ch1y	-53.98
Ch3m	-36.3
Ch3y	-63.14
Ch5y	-92.39
Ch6m	-22.7
Change	4.32%
Change From Open	5.57
Close	0.76
Days Gap	-1.18
Depreciation Amortization	2,881,000
Dollar Volume	267,785.9
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-128.7M
EBITDA	$-125.8M
EPS	$-2.07
F Score	3
FCF	$-125M
FCF EV Yield	-756.75x
FCF Per Share	$-1.91
Financing CF	189,000
Fiscal Year End	December
Founded	2,018
Investing CF	95,772,000
Ipr	-94.69
Iprfo	-93.37
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-04
Ma150	1.04
Ma150ch	-23.22%
Ma20	0.83
Ma20ch	-4.56%
Net CF	-26,051,000
Next Earnings Date	2026-08-11
Open	0.75
Optionable	No
Position In Range	84.17
Post Close	0.8
Postmarket Change Percent	0.51
Postmarket Price	$0.8
Ppne	64,126,000
Pre Close	0.76
Price Date	2026-08-07
Ptbv Ratio	0.54
Relative Volume	0.56x
Revenue	9,136,000x
SBC By Revenue	117.74x
Share Based Comp	10,757,000
Tr6m	-22.7%
Us State	Massachusetts
Volume	336,330
Z Score	-4.59

TScan Therapeutics, Inc. (TCRX)

Coverage state: Market snapshot only — no published research

Generate the first TCRX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TCRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TCRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TCRX

Frequently asked questions